August 24, 2021
Article
Ten quiz questions to assess your knowledge on common osteoporosis treatments.
August 13, 2021
The lower a person’s T-score, the lower the bone density.
November 20, 2020
Patient education is a critical component of helping patients manage this common chronic condition.
October 07, 2019
The new drug application for PF708 was submitted under the 505(b)(2) regulatory pathway with teriparatide injection as the reference drug.
July 18, 2019
Amgen is indicated to treat osteoporosis in postmenopausal women at high risk for fracture.
April 16, 2019
Approved by the FDA on April 9, 2019, Amgen’s romosozumab-aqqg therapy (Evenity) is indicated for osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy.
Top news of the day from across the health care landscape.
April 10, 2019
Romosozumab-aqqg (Evenity, Amgen) works to decrease the risk of fracture by increasing new bone formation in women with postmenopausal osteoporosis.
January 17, 2019
Top news of the day across the health care landscape.
